Trials / Completed
CompletedNCT06897878
Optimal Number of Pleural Biopsies During Pleuroscopy
OPTImal Number of Pleural BIOPsies During Pleuroscopy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 104 (actual)
- Sponsor
- Icahn School of Medicine at Mount Sinai · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A single-center, non-randomized, prospective observational, pilot study designed to determine what is the optimal number of pleural biopsies to take during pleuroscopy.
Detailed description
After enrollment, participants will undergo pleural biopsies via pleuroscopy. Specimens will be divided into three aliquots (1-3, 4-6, 7-10), which will be sent to pathology. A designated pathologist will evaluate the specimens in each aliquot to determine the number of biopsies required to reach a diagnosis and to obtain sufficient material for biomarker testing (when needed), and determine whether analysis of further aliquots is needed.
Conditions
Timeline
- Start date
- 2024-12-05
- Primary completion
- 2025-12-18
- Completion
- 2025-12-18
- First posted
- 2025-03-27
- Last updated
- 2026-02-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06897878. Inclusion in this directory is not an endorsement.